Clinical Trial Update: Multiple Transplantation of Bone Marrow Derived CD133 Cell in Cerebral Palsy [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial evaluated multiple transplantations of bone marrow–derived CD133-positive cells in individuals with cerebral palsy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Palsy

Drugs mentioned

• CD133-positive bone marrow-derived cell therapy (CD133-positive bone marrow-derived cells)

Snippet

Sponsor: Royan Institute | Conditions: Cerebral Palsy | Phase 1, Phase 2 | Status: COMPLETED